abrdn Healthcare Investors Files Definitive Proxy Statement (DEF 14A)
Ticker: HQH · Form: DEF 14A · Filed: Apr 22, 2024 · CIK: 805267
| Field | Detail |
|---|---|
| Company | Abrdn Healthcare Investors (HQH) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, DEF 14A, abrdn Healthcare Investors, Shareholder Meeting, Regulatory Filing
TL;DR
<b>abrdn Healthcare Investors has filed its Definitive Proxy Statement (DEF 14A) for its associated healthcare funds.</b>
AI Summary
abrdn Healthcare Investors (HQH) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. The filing is a Definitive Proxy Statement (DEF 14A) for abrdn Healthcare Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund. The filing date is April 22, 2024, with a report period ending June 25, 2024. The registrant is abrdn Healthcare Investors, with a business and mail address at 1900 Market Street, Suite 200, Philadelphia, PA 19103. The filing indicates no fee was required for this filing, or the fee was paid previously with preliminary materials. The document is filed under the 1934 Act, with SEC file numbers 811-04889, 811-22955, and 811-23037.
Why It Matters
For investors and stakeholders tracking abrdn Healthcare Investors, this filing contains several important signals. This DEF 14A filing is a standard regulatory requirement for publicly traded companies to inform shareholders about upcoming meetings and proposals, including director elections and executive compensation. Shareholders should review this document to understand the company's governance, executive compensation structure, and any proposed changes or resolutions that may impact their investment in abrdn Healthcare Investors and its related funds.
Risk Assessment
Risk Level: low — abrdn Healthcare Investors shows low risk based on this filing. The filing is a routine DEF 14A, which typically contains standard disclosures and does not present immediate new risks.
Analyst Insight
Review the proxy statement for details on director nominations, executive compensation, and any shareholder proposals to make informed voting decisions.
Key Numbers
- 2024-06-25 — Report Period End Date (Conformed Period of Report)
- 2024-04-22 — Filing Date (Filed As Of Date)
- 811-04889 — SEC File Number (abrdn Healthcare Investors)
- 811-22955 — SEC File Number (abrdn Healthcare Opportunities Fund)
- 811-23037 — SEC File Number (abrdn World Healthcare Fund)
Key Players & Entities
- abrdn Healthcare Investors (company) — Registrant
- abrdn Healthcare Opportunities Fund (company) — Related Fund
- abrdn World Healthcare Fund (company) — Related Fund
- 1900 Market Street (location) — Business Address
- Philadelphia, PA (location) — Business Address City/State
- 1934 Act (regulation) — SEC Act
- 811-04889 (registration_number) — SEC File Number for abrdn Healthcare Investors
- 2024-04-22 (date) — Filing Date
FAQ
When did abrdn Healthcare Investors file this DEF 14A?
abrdn Healthcare Investors filed this Proxy Statement (DEF 14A) with the SEC on April 22, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by abrdn Healthcare Investors (HQH).
Where can I read the original DEF 14A filing from abrdn Healthcare Investors?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by abrdn Healthcare Investors.
What are the key takeaways from abrdn Healthcare Investors's DEF 14A?
abrdn Healthcare Investors filed this DEF 14A on April 22, 2024. Key takeaways: The filing is a Definitive Proxy Statement (DEF 14A) for abrdn Healthcare Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund.. The filing date is April 22, 2024, with a report period ending June 25, 2024.. The registrant is abrdn Healthcare Investors, with a business and mail address at 1900 Market Street, Suite 200, Philadelphia, PA 19103..
Is abrdn Healthcare Investors a risky investment based on this filing?
Based on this DEF 14A, abrdn Healthcare Investors presents a relatively low-risk profile. The filing is a routine DEF 14A, which typically contains standard disclosures and does not present immediate new risks.
What should investors do after reading abrdn Healthcare Investors's DEF 14A?
Review the proxy statement for details on director nominations, executive compensation, and any shareholder proposals to make informed voting decisions. The overall sentiment from this filing is neutral.
How does abrdn Healthcare Investors compare to its industry peers?
The filing pertains to closed-end investment companies focused on the healthcare sector, requiring specific disclosures under SEC regulations.
Are there regulatory concerns for abrdn Healthcare Investors?
The DEF 14A filing is mandated by Section 14(a) of the Securities Exchange Act of 1934, requiring detailed information for shareholder voting.
Industry Context
The filing pertains to closed-end investment companies focused on the healthcare sector, requiring specific disclosures under SEC regulations.
Regulatory Implications
The DEF 14A filing is mandated by Section 14(a) of the Securities Exchange Act of 1934, requiring detailed information for shareholder voting.
What Investors Should Do
- Review the full DEF 14A filing for details on director nominees and their qualifications.
- Examine the executive compensation disclosures to understand pay structures and potential incentives.
- Identify and evaluate any shareholder proposals or management-sponsored resolutions to be voted upon.
Key Dates
- 2024-04-22: Filing Date — Definitive Proxy Statement (DEF 14A) filed.
- 2024-06-25: Report Period End — The period covered by the proxy statement.
Year-Over-Year Comparison
This is the initial filing of the Definitive Proxy Statement for the current reporting period.
Filing Stats: 4,535 words · 18 min read · ~15 pages · Grade level 11.9 · Accepted 2024-04-22 16:13:55
Filing Documents
- tm2410797d16_def14a.htm (DEF 14A) — 238KB
- j241079717_ba001.jpg (GRAPHIC) — 19KB
- j241079717_ba002.jpg (GRAPHIC) — 5KB
- j241079717_ba003.jpg (GRAPHIC) — 5KB
- tm2410797d16_hqhprximg01.jpg (GRAPHIC) — 136KB
- tm2410797d16_hqhprximg02.jpg (GRAPHIC) — 131KB
- tm2410797d16_thqprximg01.jpg (GRAPHIC) — 137KB
- tm2410797d16_thqprximg02.jpg (GRAPHIC) — 131KB
- tm2410797d16_thwproximg01.jpg (GRAPHIC) — 136KB
- tm2410797d16_thwproximg02.jpg (GRAPHIC) — 136KB
- 0001104659-24-049994.txt ( ) — 1395KB
From the Filing
DEF 14A 1 tm2410797d16_def14a.htm DEF 14A        UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A   SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )   Filed by the Registrant      ☒ Filed by a Party other than the Registrant       ☐ Check the appropriate box:   ☐         Preliminary Proxy Statement ☐         Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒         Definitive Proxy Statement ☐         Definitive Additional Materials ☐         Soliciting Material under §240.14a-12     abrdn Healthcare Investors abrdn Healthcare Opportunities Fund abrdn World Healthcare Fund (Name of Registrant as Specified In Its Charter)     (Name of Person(s) Filing Proxy Statement, if other than the Registrant)   Payment of Filing Fee (Check the appropriate box):   ☒        No fee required.   ☐         Fee paid previously with preliminary materials.   ☐         Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(l) and 0-11.         ABRDN HEALTHCARE INVESTORS ABRDN HEALTHCARE OPPORTUNITIES FUND ABRDN WORLD HEALTHCARE FUND 1900 Market Street, Suite 200 Philadelphia, PA 19103 NOTICE OF ANNUAL MEETINGS OF SHAREHOLDERS To be held on June 25, 2024 TO THE SHAREHOLDERS: NOTICE IS HEREBY GIVEN that the annual meeting of shareholders of each of abrdn Healthcare Investors (formerly, Tekla Healthcare Investors), abrdn Healthcare Opportunities Fund (formerly, Tekla Healthcare Opportunities Fund) and abrdn World Healthcare Fund (formerly, Tekla World Healthcare Fund) (each, a "Fund," and collectively, the "Funds") and any adjournments or postponements thereof will be held at the offices of abrdn Inc., located at 1900 Market Street, Suite 200, Philadelphia, PA 19103 (each meeting, an "Annual Meeting," and collectively, the "Annual Meetings") on the following dates and at the following times: abrdn Healthcare Investors (NYSE: HQH)   June 25, 2024   12:30 p.m. Eastern Time   abrdn Healthcare Opportunities Fund (NYSE: THQ)   June 25, 2024   1:00 p.m. Eastern Time   abrdn World Healthcare Fund (NYSE: THW)   June 25, 2024   1:30 p.m. Eastern Time   The purpose of the Annual Meetings is to consider and act upon the following proposals (each, a "Proposal") for each Fund, as applicable, and to consider and act upon such other matters as may properly come before the Annual Meetings or any adjournments or postponements thereof: HQH — To elect two Class B Trustees to serve until the 2027 Annual Meeting of Shareholders or until such Trustee's successor is duly elected and qualified. THQ — To elect two Class A Trustees to serve until the 2027 Annual Meeting of Shareholders or until such Trustee's successor is duly elected and qualified. THW — To elect two Class C Trustees to serve until the 2027 Annual Meeting of Shareholders or until such Trustee's successor is duly elected and qualified. Each Proposal is discussed in greater detail in the enclosed Joint Proxy Statement. You are entitled to notice of, and to vote at, the Annual Meeting of a Fund if you owned shares of such Fund at the close of business on April 1, 2024 (the "Record Date"). Even if you expect to attend an Annual Meeting, please complete, date, sign and return the enclosed proxy card(s) in the enclosed postage-paid envelope or authorize your proxy by telephone or through the Internet. We will admit to an Annual Meeting (1) all shareholders of record on the Record Date, (2) persons holding proof of beneficial ownership on the Record Date, such as a letter or account statement from the person's broker, (3) persons who have been granted proxies, and (4) such other persons that we, in our sole discretion, may elect to admit. All persons wishing to be admitted to an Annual Meeting must present photo identification. If you plan to attend an Annual Meeting, we ask that you call us in advance at 1-800-522-5465. This Notice and related proxy materials are first being mailed to shareholders on or about April 22, 2024. Important Notice Regarding the Availability of Proxy